JPS57123181A - Preparation of pyrazolo (1,5-a) pyridine derivative - Google Patents

Preparation of pyrazolo (1,5-a) pyridine derivative

Info

Publication number
JPS57123181A
JPS57123181A JP56008812A JP881281A JPS57123181A JP S57123181 A JPS57123181 A JP S57123181A JP 56008812 A JP56008812 A JP 56008812A JP 881281 A JP881281 A JP 881281A JP S57123181 A JPS57123181 A JP S57123181A
Authority
JP
Japan
Prior art keywords
alkyl
pyridine derivative
carboalkoxypyrazolo
catalyst
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56008812A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0378395B2 (en:Method
Inventor
Taketoshi Miura
Akira Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Paper Mills Ltd
Original Assignee
Mitsubishi Paper Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Paper Mills Ltd filed Critical Mitsubishi Paper Mills Ltd
Priority to JP56008812A priority Critical patent/JPS57123181A/ja
Publication of JPS57123181A publication Critical patent/JPS57123181A/ja
Publication of JPH0378395B2 publication Critical patent/JPH0378395B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP56008812A 1981-01-23 1981-01-23 Preparation of pyrazolo (1,5-a) pyridine derivative Granted JPS57123181A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56008812A JPS57123181A (en) 1981-01-23 1981-01-23 Preparation of pyrazolo (1,5-a) pyridine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56008812A JPS57123181A (en) 1981-01-23 1981-01-23 Preparation of pyrazolo (1,5-a) pyridine derivative

Publications (2)

Publication Number Publication Date
JPS57123181A true JPS57123181A (en) 1982-07-31
JPH0378395B2 JPH0378395B2 (en:Method) 1991-12-13

Family

ID=11703229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56008812A Granted JPS57123181A (en) 1981-01-23 1981-01-23 Preparation of pyrazolo (1,5-a) pyridine derivative

Country Status (1)

Country Link
JP (1) JPS57123181A (en:Method)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030538A3 (en) * 2008-09-11 2010-05-06 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis c
US7994171B2 (en) 2008-09-11 2011-08-09 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8048887B2 (en) 2008-09-11 2011-11-01 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8293909B2 (en) 2008-09-11 2012-10-23 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8324212B2 (en) 2010-02-25 2012-12-04 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8354410B2 (en) 2010-03-11 2013-01-15 Bristol-Meyers Squibb Company Compounds for the treatment of hepatitis C
US8445497B2 (en) 2010-06-30 2013-05-21 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8507722B2 (en) 2002-05-20 2013-08-13 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9303020B2 (en) 2012-02-08 2016-04-05 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4955615A (en:Method) * 1972-08-07 1974-05-30

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4955615A (en:Method) * 1972-08-07 1974-05-30

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507722B2 (en) 2002-05-20 2013-08-13 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8293909B2 (en) 2008-09-11 2012-10-23 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US7994171B2 (en) 2008-09-11 2011-08-09 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
JP2012502099A (ja) * 2008-09-11 2012-01-26 ブリストル−マイヤーズ スクイブ カンパニー Ｃ型肝炎の治療のための化合物
US8148382B2 (en) 2008-09-11 2012-04-03 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8198449B2 (en) 2008-09-11 2012-06-12 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
WO2010030538A3 (en) * 2008-09-11 2010-05-06 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis c
US8309558B2 (en) 2008-09-11 2012-11-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8722688B2 (en) 2008-09-11 2014-05-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8536338B2 (en) 2008-09-11 2013-09-17 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8048887B2 (en) 2008-09-11 2011-11-01 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8324212B2 (en) 2010-02-25 2012-12-04 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8354410B2 (en) 2010-03-11 2013-01-15 Bristol-Meyers Squibb Company Compounds for the treatment of hepatitis C
US8445497B2 (en) 2010-06-30 2013-05-21 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US9303020B2 (en) 2012-02-08 2016-04-05 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C

Also Published As

Publication number Publication date
JPH0378395B2 (en:Method) 1991-12-13

Similar Documents

Publication Publication Date Title
JPS57123181A (en) Preparation of pyrazolo (1,5-a) pyridine derivative
JPS57158769A (en) Preparation of 2-substituted hydroxyimino-2-(5-amino-1,2,4- thiadiazol-3-yl)acetic acid or its salt, and their intermediate
JPS5566550A (en) Preparation of o-(2,6-dichloroanilino)-phenylacetic acid
JPS5711981A (en) Theobromine derivative and its preparation
JPS54122220A (en) Preparation of high purity isoprenyl acetic acid
JPS5536431A (en) Preparation of farnesylacetic acid
JPS5566551A (en) Preparation of o-(2,6-dichloroanilino)-phenylacetic acid
JPS5576881A (en) Preparation of high-purity coproporphyrin 3 alkali salt
JPS5573654A (en) Preparation of unsaturated ketone compound
JPS5724361A (en) Preparation of indole derivative
JPS57154164A (en) Preparation of dl-cysteine or cystine
JPS56147784A (en) Preparation of beta-quinophthalone
JPS57102875A (en) 5-acylamino-4-methyloxazole and its preparation
JPS5531029A (en) Preparation of 4-substituted amido-3-arylamino-5- pyrazolones
JPS572268A (en) Preparation of 5- p-chlorobenzoyl -1,4-dimethylpyrrole- 2-acetic acid
JPS55157579A (en) Preparation of raw material for polycondensation
JPS55102537A (en) Preparation of 4-hydroxymandelic acid
JPS5492989A (en) Preparation of substituted theobromine
JPS54157560A (en) Preparation of n-substituted imidazole derivative
JPS5536436A (en) Production of pyrido 2,3-d pyrimidinecarboxylic acid derivative
JPS5732254A (en) Novel preparation of (s)-(-)-1-alkylamino-3-aryl- oxypropane-2-ol
JPS5524117A (en) Preparation of 2-(3-benzoylphenyl) propionic acid
JPS57169458A (en) Preparation of indole derivative
JPS54141723A (en) Preparation of beta-hydroxyamino acid
JPS57134453A (en) Polyprenylacetone hydrazone derivative and its preparation